Organon International, Inc. is a pharmaceutical company headquartered in Roseland, New Jersey that is part of Akzo Nobel. When the company was first formed it originally maintained its headquarters, research and development and sales offices in three buildings it owned in neighboring West Orange, New Jersey however the company moved out of West Orange citing high property taxes, the buildings were put up for sale however as of this writing there has been no takers and the properties are basically sitting empty and abandoned.

Organon deals in the following core therapeutic fields: reproductive medicine, contraception, psychiatry and anesthesia. Organon sells to international markets.

Organon creates, manufactures, and markets prescription medicines that improve the health and quality of human life. With approximately 1,800 employees, Organon USA has two corporate locations in the United States. Headquarters are located in Roseland, New Jersey. Organon USA also operates a 174,000-square-foot packaging and distribution center in Allentown, Pennsylvania. On a global level, Organon is headquartered in both Roseland, New Jersey, United States and Oss, the Netherlands. Organon products are sold in more than 100 countries — more than half of which have an Organon subsidiary. Oss, the Netherlands headquarters, is also home to a state-of-the art parenteral production facility. In Cambridge, Massachusetts, Organon maintains a new biotechnology research facility. Another research facility is located in Newhouse, Scotland.

Organon was founded in 1923 and is now a business unit of the healthcare group of Akzo Nobel N.V. Today, Organon has more than 13,000 employees worldwide. Akzo Nobel N.V., based in the Netherlands, serves customers throughout the world with healthcare products, coatings, and chemicals. Organon is the human healthcare business. Intervet is one of the world’s top three producers of animal healthcare products. Operating independently under the Organon umbrella is Diosynth, a technology-based manufacturer of active pharmaceutical ingredients for the third-party market. Also included in Akzo Nobel’s healthcare group is Nobilon International, a fully integrated biotechnology company that is dedicated to exploring opportunities in the field of human vaccines.

Organon was founded by Dr.Saal van Zwanenberg in Oss, the Netherlands, in 1923 as Zwanenberg-Organon. Its first product was insulin. In the thirties it manufactured estrogens. The production of cortison was initiated in 1953. The now named Koninklijke Zwanenberg-Organon (KZO) fused with the fiber producer AKU in 1969 to become AKZO, later Akzo Nobel. Organon is the human health care business unit of Akzo Nobel and transferred its headquarters to the USA while the main headquarter of Akzo Nobel remains in Arnhem. Manufacturing facilities are in the Netherlands, Germany, the United Kingdom, China, Japan, and the USA.

Akzo Nobel currently employs almost 62,000 people in more than 80 countries. Sales in 2004 aggregated EUR 12.7 billion, of which 25 percent was in pharma products, 41 percent in coatings, and 34 percent in chemicals. More information on Akzo Nobel is available at www.akzonobel.com. (NASDAQ: AKZOY)

External links

• Official website

Pharmaceutical companies of the United States | Biotechnology companies | Companies based in New Jersey

Organon (Pharma) | Organon (multinational)